Asian Paints, Berger Paints, Dabur, HUL, TCS : Are the Famed Consistent Compounders in for a Lost Decade?

Why It Matters

Investors who continue to allocate to legacy compounders at premium multiples may face prolonged underperformance, reshaping portfolio construction across Indian equity funds. The shift underscores the need to reassess valuation discipline in a higher‑rate, lower‑liquidity environment.

Key Takeaways

• Consistent compounders posted sub‑3% CAGR since 2019
• Valuations remain 2‑3x Nifty despite weak returns
• Profit growth halved across Asian Paints, Dabur, TCS
• Market shift from cheap money to higher yields
• Turnaround requires valuation compression or growth acceleration

Pulse Analysis

The allure of India’s “consistent compounders” grew out of a decade where brands like Asian Paints, Hindustan Unilever and TCS not only dominated their sectors but also delivered double‑digit shareholder returns. Between 2009 and 2019, these companies compounded earnings at 18‑26% annually, translating into 20‑30% stock price appreciation, far outpacing the Nifty 50’s 8.9% pace. This track record cemented a narrative that strong fundamentals could justify lofty price‑to‑earnings multiples, often exceeding 70x, and attracted a wave of passive and active capital seeking “safe” growth.

The post‑COVID environment, however, introduced a stark reversal. Global interest rates rose, liquidity tightened and foreign investors gravitated toward higher‑yielding bonds, prompting a re‑pricing of equity risk. Simultaneously, sector‑specific headwinds—slower paint volume growth, FMCG competition, and tighter credit conditions for banks—eroded earnings momentum. As a result, profit‑growth CAGR for Asian Paints fell from 18.1% to 8.7%, Dabur’s slipped to 3.1%, and TCS’s to 7.3% over the FY19‑FY25 span. Stock‑return CAGRs collapsed to single‑digit or negative figures, while valuations, though lower than their peaks, still sit at 48‑64 times earnings, well above the Nifty’s 21x.

For investors, the lesson is twofold. First, strong brand moats no longer guarantee superior market returns when valuations are detached from realistic growth forecasts. Second, portfolio managers must blend the historic resilience of these firms with a disciplined assessment of forward‑looking earnings and macro‑economic conditions. Strategies may involve trimming exposure until multiples align with sustainable growth, or reallocating to sectors benefiting from the current rate‑sensitive landscape. Ultimately, the era of “buy‑and‑hold forever” for legacy compounders is over; disciplined valuation analysis will dictate future alpha.